Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Bond Issue

11 Jun 2025 09:37

RNS Number : 3871M
Experian plc
11 June 2025
Β 

Β 

Experian plc

Β 

Β 

Bond Issue

Β 

Β 

11 June 2025 - Experian plc, the global data and technology company, announces that its subsidiary, Experian Finance plc, rated A3 / A-, has priced an issue of $500million 5.250% bonds due 17 August 2035 (the "Notes"). The Notes will be issued by Experian Finance plc and guaranteed byΒ Experian plc.

Β 

This bond issue extends the maturity of the Group's debt portfolio and diversifies its funding sources. The net proceeds of the offering will be used for general corporate purposes, including potential acquisitions and the repayment of debt. The issue is scheduled to close on 17 June 2025, subject to customary conditions.

Β 

It is expected that the Notes will be admitted to the official list of Euronext Dublin and admitted to trading on the Global Exchange Market.

Β 

The Notes are being sold to qualified institutional buyers in the United States in accordance with Rule 144A under the US Securities Act of 1933Β ("Securities Act"), and to non-US persons outside the United States in reliance upon Regulation S under the Securities Act. The Notes and the guarantee have not been, and will not be, registered under the Securities Act, or the securities laws of any state of the United States or other jurisdiction, and may not be offered or sold in the United Sates, or to, or for the account or benefit of, US persons, other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Β 

This announcement does not constitute or form part of any offer or any solicitation to purchase nor shall it, or the fact of its distribution, form the basis of, or be relied on in any purchase. The distribution of this announcement and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this announcement or any subsequent offer should inform themselves about and observe any such restriction. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

Β 

Β 

Contact:

Β 

Experian

Remco de Vries Group Treasurer +353 (0) 86 380 2791

Lorraine Keogh Deputy Group Treasurer +353 (0) 86 380 2193

Β 

Β 

About Experian

Β 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Β 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IODSFISAFEISEDM
Date   Source Headline
7th Feb 20249:14 amRNSAdditional Listing
6th Feb 20243:47 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
31st Jan 20249:20 amRNSAdditional Listing
24th Jan 20249:47 amRNSAdditional Listing
17th Jan 202412:44 pmRNSDirector/PDMR Shareholding
17th Jan 20249:44 amRNSAdditional Listing
16th Jan 20247:00 amRNSExperian Q3 FY24 trading update
12th Jan 20245:44 pmRNSFirst Interim Dividend
10th Jan 202410:55 amRNSAdditional Listing
3rd Jan 20249:02 amRNSAdditional Listing
29th Dec 202310:03 amRNSTotal Voting Rights
15th Dec 20239:32 amRNSElections for first interim dividend
13th Dec 20239:31 amRNSAdditional Listing
6th Dec 20239:14 amRNSAdditional Listing
30th Nov 202312:14 pmRNSTotal Voting Rights
29th Nov 20239:43 amRNSAdditional Listing
22nd Nov 20239:25 amRNSAdditional Listing
15th Nov 20237:00 amRNSHalf-year Report
10th Nov 20239:00 amRNSDirector Declaration
31st Oct 20235:04 pmRNSTransaction in Own Shares
31st Oct 202312:22 pmRNSTotal Voting Rights
30th Oct 20235:13 pmRNSTransaction in Own Shares
27th Oct 20235:32 pmRNSTransaction in Own Shares
26th Oct 20235:44 pmRNSTransaction in Own Shares
25th Oct 20235:17 pmRNSTransaction in Own Shares
24th Oct 20235:42 pmRNSTransaction in Own Shares
11th Oct 20239:46 amRNSAdditional Listing
6th Oct 20233:30 pmRNSShare repurchase programme
4th Oct 20239:04 amRNSAdditional Listing
27th Sep 20235:07 pmRNSTransaction in Own Shares
27th Sep 20239:50 amRNSAdditional Listing
26th Sep 20235:08 pmRNSTransaction in Own Shares
25th Sep 20235:47 pmRNSTransaction in Own Shares
20th Sep 20239:13 amRNSAdditional Listing
19th Sep 20232:45 pmRNSBlock listing Interim Review
13th Sep 20239:30 amRNSAdditional Listing
31st Aug 202312:32 pmRNSTotal Voting Rights
30th Aug 20239:25 amRNSAdditional Listing
23rd Aug 20235:34 pmRNSTransaction in Own Shares
23rd Aug 20239:32 amRNSAdditional Listing
22nd Aug 20235:54 pmRNSTransaction in Own Shares
16th Aug 20239:16 amRNSAdditional Listing
9th Aug 20239:30 amRNSAdditional Listing
2nd Aug 20239:16 amRNSAdditional Listing
31st Jul 202312:05 pmRNSTotal Voting Rights
26th Jul 202310:00 amRNSAdditional Listing
25th Jul 20232:30 pmRNSDirector/PDMR Shareholding
25th Jul 202310:30 amRNSDirector/PDMR Shareholding
19th Jul 20232:32 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.